Strategies for the use of Ginkgo biloba extract, EGb 761(R), in the treatment and management of mild cognitive impairment in Asia: Expert consensus

• Main Authors: Kandiah, Nagaendran, Chan, Yee Fai, Chen, Christopher, Dasig, Darwin, Dominguez, Jacqueline, Han, Seol-Heui, Jia, Jianping, Kim, SangYun, Limpawattana, Panita, Ng, Li-Ling, Nguyen, Dinh Toan, Ong, Paulus Anam, Raya-Ampil, Encarnita, Saedon, Nor'izzati, Senanarong, Vorapun, Setiati, Siti, Singh, Harjot, Suthisisang, Chuthamanee, Trang, Tong Mai, Turana, Yuda, Venketasubramanian, Narayanaswamy, Yong, Fee Mann, Youn, Yong Chul, Ihl, Ralf
• Format: Article
• Published: Wiley 2021
• Subjects: RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry
• Online Access: http://eprints.um.edu.my/34617/

Background Mild cognitive impairment (MCI) is a neurocognitive state between normal cognitive aging and dementia, with evidence of neuropsychological changes but insufficient functional decline to warrant a diagnosis of dementia. Individuals with MCI are at increased risk for progression to dementia...